Literature DB >> 1372159

Biologic and immunohistochemical analysis of interleukin-6 expression in vivo. Constitutive and induced expression in murine polymorphonuclear and mononuclear phagocytes.

P D Terebuh1, I G Otterness, R M Strieter, P M Lincoln, J M Danforth, S L Kunkel, S W Chensue.   

Abstract

Interleukin-6 (IL-6) is considered an important multifunctional cytokine involved in the regulation of a variety of cellular responses, including the induction of acute-phase protein synthesis, lymphocyte activation, and hematopoiesis. In vitro studies have identified many cells that can produce IL-6, but the cellular sources under physiologic conditions have yet to be identified. Using immunoaffinity purified goat anti-murine IL-6, the authors performed immunohistochemical studies to localize cells expressing IL-6 in selected organs of normal and endotoxin challenged NIH-Swiss outbred mice. In the blood, findings were correlated with cell-associated bioactivity using the standard B9 cell proliferation assay. In normal mice, constitutive expression was seen in granulocytes, monocytes and their precursors as well as in bone marrow and splenic stromal macrophages. Hepatic macrophages were negative, as were lymphocytes, megakaryocytes, erythroid precursors, and endothelial cells. In the absence of significant serum levels of IL-6, cell-associated IL-6 bioactivity was detected in circulating polymorphonuclear leukocytes (PMNs), but not lymphocytes. After endotoxin challenge, there was a threefold increase in PMN IL-6 content from 1 to 3 hours followed by almost complete depletion at 6 hours. This correlated well with a threefold increase of IL-6 mRNA in the bone marrow followed by a decrease at 6 hours. This pattern also correlated with serum levels of IL-6, which peaked at 3 hours and dropped significantly by 6 hours. By 24 hours, cell-associated IL-6 showed recovery with no increase in serum levels. In vivo findings showing IL-6 expression in bone marrow macrophages support in vitro studies suggesting a role for IL-6 in hematopoiesis. Furthermore, PMNs as well as macrophages are likely important sources of IL-6 during inflammatory and septic states.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372159      PMCID: PMC1886159     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  21 in total

1.  Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes.

Authors:  J V Castell; M J Gómez-Lechón; M David; T Andus; T Geiger; R Trullenque; R Fabra; P C Heinrich
Journal:  FEBS Lett       Date:  1989-01-02       Impact factor: 4.124

2.  A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro.

Authors:  R P Nordan; M Potter
Journal:  Science       Date:  1986-08-01       Impact factor: 47.728

3.  Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha.

Authors:  N A Cicco; A Lindemann; J Content; P Vandenbussche; M Lübbert; J Gauss; R Mertelsmann; F Herrmann
Journal:  Blood       Date:  1990-05-15       Impact factor: 22.113

4.  Genes for IFN-beta-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals.

Authors:  M G Tovey; J Content; I Gresser; J Gugenheim; B Blanchard; J Guymarho; P Poupart; M Gigou; A Shaw; W Fiers
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

5.  Release of gelatinase from a novel secretory compartment of human neutrophils.

Authors:  B Dewald; U Bretz; M Baggiolini
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

6.  Transcriptional regulation of the interferon-beta 2/B cell differentiation factor BSF-2/hepatocyte-stimulating factor gene in human fibroblasts by other cytokines.

Authors:  Z Walther; L T May; P B Sehgal
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

7.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

8.  In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects.

Authors:  S W Chensue; P D Terebuh; D G Remick; W E Scales; S L Kunkel
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

9.  Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.

Authors:  J Van Snick; S Cayphas; A Vink; C Uyttenhove; P G Coulie; M R Rubira; R J Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Synergism of BSF-2/interleukin 6 and interleukin 3 on development of multipotential hemopoietic progenitors in serum-free culture.

Authors:  K Koike; T Nakahata; M Takagi; T Kobayashi; A Ishiguro; K Tsuji; K Naganuma; A Okano; Y Akiyama; T Akabane
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  11 in total

1.  Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation.

Authors:  Delbert S Abi Abdallah; Charlotte E Egan; Barbara A Butcher; Eric Y Denkers
Journal:  Int Immunol       Date:  2011-03-21       Impact factor: 4.823

2.  Estriol: a potent regulator of TNF and IL-6 expression in a murine model of endotoxemia.

Authors:  S H Zuckerman; S E Ahmari; N Bryan-Poole; G F Evans; L Short; A L Glasebrook
Journal:  Inflammation       Date:  1996-12       Impact factor: 4.092

Review 3.  Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

Authors:  W L Biffl; E E Moore; F A Moore; V M Peterson
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

4.  IgE receptor-positive non-B/non-T cells dominate the production of interleukin 4 and interleukin 6 in immunized mice.

Authors:  I Aoki; C Kinzer; A Shirai; W E Paul; D M Klinman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly.

Authors:  Adriana Lima Vallochi; Anna Carla Goldberg; Angela Falcai; Rajendranath Ramasawmy; Jorge Kalil; Cláudio Silveira; Rubens Belfort; Luiz Vicente Rizzo
Journal:  Clin Ophthalmol       Date:  2008-12

6.  Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inflammatory response.

Authors:  W Chen; E A Havell; F Gigliotti; A G Harmsen
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

7.  Temporal profile of cerebrospinal fluid, plasma, and brain interleukin-6 after normothermic fluid-percussion brain injury: effect of secondary hypoxia.

Authors:  Katina Chatzipanteli; Elizabeth Vitarbo; Ofelia F Alonso; Helen M Bramlett; W Dalton Dietrich
Journal:  Ther Hypothermia Temp Manag       Date:  2012-12       Impact factor: 1.286

8.  Secondary necrotic neutrophils release interleukin-16C and macrophage migration inhibitory factor from stores in the cytosol.

Authors:  S Roth; M Agthe; S Eickhoff; S Möller; C M Karsten; N Borregaard; W Solbach; T Laskay
Journal:  Cell Death Discov       Date:  2015-11-30

9.  Elevated Notch ligands in serum are associated with HIV/TB coinfection.

Authors:  Jennifer R Bermick; Pamela M Lincoln; Ronald M Allen; Steven L Kunkel; Matthew A Schaller
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-06-27

10.  Regulation of Neutrophil Degranulation and Cytokine Secretion: A Novel Model Approach Based on Linear Fitting.

Authors:  Isabelle Naegelen; Nicolas Beaume; Sébastien Plançon; Véronique Schenten; Eric J Tschirhart; Sabrina Bréchard
Journal:  J Immunol Res       Date:  2015-10-22       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.